{"title":"代表病人进行干预。","authors":"Bob Carlson","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Adherence to a biologic treatment regimen is essential for tracking efficacy and justifying its cost. That's where medication therapy management services come in.Pharmacists are providing medication therapy management (MTM) services for patients taking biologics, although studies to demonstrate its cost-effectiveness are lacking. Is this the best way to ensure that high-cost, high-impact biologics are used correctly?</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 1","pages":"10-5"},"PeriodicalIF":0.0000,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086129/pdf/bth08_1p010.pdf","citationCount":"0","resultStr":"{\"title\":\"Intervening on behalf of patients.\",\"authors\":\"Bob Carlson\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Adherence to a biologic treatment regimen is essential for tracking efficacy and justifying its cost. That's where medication therapy management services come in.Pharmacists are providing medication therapy management (MTM) services for patients taking biologics, although studies to demonstrate its cost-effectiveness are lacking. Is this the best way to ensure that high-cost, high-impact biologics are used correctly?</p>\",\"PeriodicalId\":89534,\"journal\":{\"name\":\"Biotechnology healthcare\",\"volume\":\"8 1\",\"pages\":\"10-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086129/pdf/bth08_1p010.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biotechnology healthcare\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology healthcare","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Adherence to a biologic treatment regimen is essential for tracking efficacy and justifying its cost. That's where medication therapy management services come in.Pharmacists are providing medication therapy management (MTM) services for patients taking biologics, although studies to demonstrate its cost-effectiveness are lacking. Is this the best way to ensure that high-cost, high-impact biologics are used correctly?
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
